title: [Immunosuppression following venous allografts transplantations--the authors' experience].
abstract: OBJECTIVE
  Venous and arterial graft usage in vascular reconstructions was re-discovered in connection with organ transplantation development. Allografts are employed in many clinics, however, uniform opinion on the use of immunosuppression after the procedure of venous graft transfer from a cadaveric donor, is still lacking.
  
  
  METHODS
  The authors present their own group of patients who underwent vascular reconstructions, and in whom allogenic vein was used. The majority of indications for bypass procedures resulted from critical limb ischemia. Immunosuppressive medication was administered during the vascular procedure and, over the past several years, it purely consisted of tacrolimus monotherapy.
  
  
  RESULTS
  In the group of 101 patients, no serious complications due to adverse effects of immunosuppression therapy were recorded.
authors.affiliation: KTCH IKEM Praha. miad@ikem.cz
authors.forename: M
authors.initials: M
authors.lastname: Adamec
authors.forename: I
authors.initials: I
authors.lastname: Matia
authors.forename: L
authors.initials: L
authors.lastname: Janousek
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D014184:Transplantation, Homologous; D014656:Vascular Surgical Procedures; D014680:Veins / Q000637:transplantation*
chemical_list: D007166:Immunosuppressive Agents